medigraphic.com
ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México

2012, Number 2

<< Back Next >>

Arch Med Urg Mex 2012; 4 (2)

Prevalence of the metabolic syndrome in patients with acute coronary syndrome

Aguilar DÓ, Cruz HME

Language: Spanish
References: 19
Page: 59-64
PDF size: 54.91 Kb.


ABSTRACT

Background: Diabetes mellitus (DM 2) and acute coronary syndrome (ACS) occupy the two leading causes of morbidity mortality in Mexico. The clinical importance of metabolic syndrome (MS) is to be identificable and correctable precursor of diabetes and cardiovascular disease. Objective: To determine the prevalence of the metabolic syndrome in patients with coronary syndrome acute. Methodology: Prospective cross-sectional study. Adults with the diagnosis corroborated SICA have been studied and you are looking for the presence of SM NACEP (ATP III) criteria. Results: They were collected 110 (N) patients, 66.3% male and 33.6% female, with an average age of 62.5 years. 76.3% had acute myocardial infarction and 23.6% unstable angina. Gurantee the diagnosis of SM in 67.2% of patients with 59.4% were male and 40.5% women. SICA and SM Association found: 58 patients with acute myocardial infarction, 16 SM and unstable angina, 26 SM and acute myocardial infarction and 10 SM and unstable angina and SM. Conclusions: The metabolic syndrome occurs in three quarters of patients admitted to emergency with diagnosis of acute coronary syndrome. The foregoing suggests that the early diagnosis and prompt treatment of metabolic syndrome will impact on the incidence of ACS.


REFERENCES

  1. González R. Síndrome metabólico: algunos aspectos biológicos y epidemiológicos. Educación Permanente en Salud 2006; 30: 1-9.

  2. Peralta M. Definición de síndrome metabólico: La Torre de Babel. Archivos de Cardiología 2005; 75: 230-233.

  3. Grundy S, Hansen B, Sidney C, Smith S, Cleeman J, Kahn R. Clinical management of metabolic syndrome. Circulation 2004; 109: 551-556.

  4. González A, Lavalle F, Ríos. Síndrome metabólico y enfermedad cardiovascular. México: Intersistemas, 2004: 41: 87-123.

  5. Day C. Metabolic syndrome, or what you will: definitions and epidemiology. Diab Vasc Dis Res 2007; 4: 32-38.

  6. Solymoss B, Bourassa M, Campeau L, Sniderman A, Marcil M, Lespérance et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93: 159-164.

  7. Opie L. Metabolic syndrome. Circulation 2007; 115: 2-35.

  8. Ceceña L. Tratamiento de los síndromes coronarios agudos en pacientes diabéticos o con síndrome metabólico. Arch Cardiol Mex 2004; 74: S275-280.

  9. Aguilar-Salinas C, Rojas R, Gómez-Pérez J, Franco A, Olaiz G, Juan, Rull J et al. El síndrome metabólico: un concepto en evolución. Gac Med Mex 2004; 140: S41-48.

  10. Levantesi G, Macchia A, Marfisi R, Franzosi M, Maggioni A, Nicolosi G et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005; 46 (2): 277-283.

  11. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486-2497.

  12. Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract 2005; 68S1: S2-9.

  13. Carrillo R, Sánchez M, Argueda S. Síndrome metabólico. Revista Facultad de Medicina UNAM 2006; 49 (3): 98-104.

  14. González A. Consenso Mexicano de Resistencia a la Insulina y Síndrome Metabólico. Revista Mexicana de Cardiología 1999; 41: 87-123.

  15. Echeverría M, Hernández A, Alcocer M, Morales H, Vázquez A. Síndrome metabólico en adultos de 20 a 40 años en una comunidad rural mexicana. Rev Med Inst Mex Seguro Soc 2006; 44 (4): 329-335.

  16. Rosas M, Attié F. Enfermedad cardiovascular. Primera causa de muerte en adultos de México y el mundo. Arch Mex Cardiol 2007; 77 (2): 91-93.

  17. Bueno H. Síndrome coronario agudo: Un concepto clínico de rápida evolución. Cardiovascular Risk Factors 2003; 12 (6): 335-337.

  18. Ford E, MD, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults. JAMA 2002; 287 (3): 356-359.

  19. Adrian J, Cameron A, Shaw J, Zimmet. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; (33): 351-375.




2020     |     www.medigraphic.com